Sandra Milligan - May 4, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of Research & Development
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Stock symbol
OGN
Transactions as of
May 4, 2023
Transactions value $
-$52,552
Form type
4
Date filed
5/8/2023, 06:43 PM
Previous filing
May 3, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +4.98K +19.33% 30.8K May 4, 2023 Direct F1
transaction OGN Common Stock Tax liability -$52.6K -2.17K -7.05% $24.24 28.6K May 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -4.98K -50% $0.00 4.98K May 4, 2023 Common Stock 4.99K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.